Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 16,168 | 12,856 | 11,271 | 10,396 | 0 |
| Operating Income | -16,168 | -12,856 | -11,271 | -10,396 | N/A |
| Interest Expense | 938 | 918 | 736 | 439 | 0 |
| Other Income | 425 | 423 | 449 | 486 | 0 |
| Pre-tax Income | -16,681 | -13,351 | -11,558 | -10,349 | 0 |
| Net Income Continuous | -16,672 | -13,351 | -11,558 | -10,349 | N/A |
| Net Income | $-16,672 | $-13,351 | $-11,558 | $-10,349 | $N/A |
| EPS Basic Total Ops | 121.54 | -51.43 | -45.30 | -41.12 | N/A |
| EPS Basic Continuous Ops | 102.25 | -44.36 | -38.40 | -33.82 | N/A |
| EPS Diluted Total Ops | 121.54 | -51.43 | -45.30 | -41.12 | N/A |
| EPS Diluted Continuous Ops | 102.25 | -44.36 | -38.40 | -33.82 | N/A |
| EBITDA(a) | $-16,089 | $-12,781 | $-11,204 | $-10,350 | $N/A |